Capsos Medical is pioneering a new treatment of Chronic Total Occlusions (CTO’s) which are complete blockages of an artery resulting in reduced blood flow and a lower quality of life. Their breakthrough ‘CapBuster’ solution is a balloon catheter and guidewire combination device that provides physicians with an easy-to-use and innovative solution which will re-open the most resistant occlusions where a calcified cap has formed on the surface of the blockage. The WDC participated in the company’s seed round in 2014, co-investing with the AIB Seed Capital Fund and the AIB Early Stage Fund as well as EI, IRRUS Angel Syndicate and the MedTech Syndicate to develop the product and achieve regulatory approval.